These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 35468850)
21. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples]. Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229 [TBL] [Abstract][Full Text] [Related]
22. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE. Beynon R; Leeflang MM; McDonald S; Eisinga A; Mitchell RL; Whiting P; Glanville JM Cochrane Database Syst Rev; 2013 Sep; 2013(9):MR000022. PubMed ID: 24022476 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2. Tollånes MC; Bakken Kran AM; Abildsnes E; Jenum PA; Breivik AC; Sandberg S Clin Chem Lab Med; 2020 Aug; 58(9):1595-1600. PubMed ID: 32598303 [TBL] [Abstract][Full Text] [Related]
24. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting. Skittrall JP; Wilson M; Smielewska AA; Parmar S; Fortune MD; Sparkes D; Curran MD; Zhang H; Jalal H Clin Microbiol Infect; 2021 Mar; 27(3):469.e9-469.e15. PubMed ID: 33068757 [TBL] [Abstract][Full Text] [Related]
25. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples. Nóra M; Déri D; Veres DS; Kis Z; Barcsay E; Pályi B PLoS One; 2022; 17(2):e0262399. PubMed ID: 35157700 [TBL] [Abstract][Full Text] [Related]
26. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cruciani M; Mengoli C; Barnes R; Donnelly JP; Loeffler J; Jones BL; Klingspor L; Maertens J; Morton CO; White LP Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009551. PubMed ID: 31478559 [TBL] [Abstract][Full Text] [Related]
27. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study. Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461 [TBL] [Abstract][Full Text] [Related]
29. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726 [TBL] [Abstract][Full Text] [Related]
30. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J Cochrane Database Syst Rev; 2015 Sep; (9):CD009551. PubMed ID: 26343815 [TBL] [Abstract][Full Text] [Related]
31. Forcing dichotomous disease classification from reference standards leads to bias in diagnostic accuracy estimates: A simulation study. Jenniskens K; Naaktgeboren CA; Reitsma JB; Hooft L; Moons KGM; van Smeden M J Clin Epidemiol; 2019 Jul; 111():1-10. PubMed ID: 30904568 [TBL] [Abstract][Full Text] [Related]
32. Performance verification of five commercial RT-qPCR diagnostic kits for SARS-CoV-2. Yang M; Cao S; Liu Y; Zhang Z; Zheng R; Li Y; Zhou J; Zong C; Cao D; Qin X Clin Chim Acta; 2022 Jan; 525():46-53. PubMed ID: 34902345 [TBL] [Abstract][Full Text] [Related]
34. Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens. De Pace V; Caligiuri P; Ricucci V; Nigro N; Galano B; Visconti V; Da Rin G; Bruzzone B BMC Infect Dis; 2021 Sep; 21(1):926. PubMed ID: 34493222 [TBL] [Abstract][Full Text] [Related]
35. Imaging tests for the detection of osteomyelitis: a systematic review. Llewellyn A; Jones-Diette J; Kraft J; Holton C; Harden M; Simmonds M Health Technol Assess; 2019 Oct; 23(61):1-128. PubMed ID: 31670644 [TBL] [Abstract][Full Text] [Related]
36. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Waugh J; Hooper R; Lamb E; Robson S; Shennan A; Milne F; Price C; Thangaratinam S; Berdunov V; Bingham J Health Technol Assess; 2017 Oct; 21(61):1-90. PubMed ID: 29064366 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of diagnostic tests for low prevalence diseases: a statistical approach for leveraging real-world data to accelerate the study. Chen WC; Li H; Wang C; Lu N; Song C; Tiwari R; Xu Y; Yue LQ J Biopharm Stat; 2021 May; 31(3):375-390. PubMed ID: 33615997 [TBL] [Abstract][Full Text] [Related]
38. Real-world evaluation of rapid and laboratory-free COVID-19 triage for emergency care: external validation and pilot deployment of artificial intelligence driven screening. Soltan AAS; Yang J; Pattanshetty R; Novak A; Yang Y; Rohanian O; Beer S; Soltan MA; Thickett DR; Fairhead R; Zhu T; Eyre DW; Clifton DA; Lancet Digit Health; 2022 Apr; 4(4):e266-e278. PubMed ID: 35279399 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a decided sample size in machine learning applications. Rajput D; Wang WJ; Chen CC BMC Bioinformatics; 2023 Feb; 24(1):48. PubMed ID: 36788550 [TBL] [Abstract][Full Text] [Related]
40. Optimizing prevalence estimates for a novel pathogen by reducing uncertainty in test characteristics. Larremore DB; Fosdick BK; Zhang S; Grad YH Epidemics; 2022 Dec; 41():100634. PubMed ID: 36191537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]